We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

TOward the Lowest Effective DOse of Abatacept or Tocilizumab (TOLEDO)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01557374
Recruitment Status : Active, not recruiting
First Posted : March 19, 2012
Last Update Posted : June 21, 2016
Ministry of Health, France
Information provided by (Responsible Party):
Assistance Publique - Hôpitaux de Paris

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Active, not recruiting
  Estimated Primary Completion Date : June 2018
  Estimated Study Completion Date : June 2018